Stocktoria
Scienture Holdings, Inc. SCNX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-02-18
Scienture Holdings, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $431,609 | $136,643 | $1.4M | $10.3M | $9.9M |
| Gross profit | $331,482 | $6,005 | $49,030 | $5.5M | $4.7M |
| R&D expense | $2.0M | $2.2M | — | — | — |
| Operating income | -$42.6M | -$14.7M | -$4.4M | -$2.9M | -$5.3M |
| Interest expense | — | — | $1.2M | $336,206 | $23,590 |
| Income tax | -$2.0M | -$534,396 | — | — | — |
| Net income | -$41.5M | $9.1M | -$17.8M | -$3.5M | -$5.3M |
| EPS (diluted) | $-2.70 | $2.48 | $-23.35 | $-6.13 | $-0.65 |
| Operating cash flow | -$13.4M | -$14.3M | $3.6M | -$1.5M | -$2.6M |
| Free cash flow | — | -$14.3M | — | — | -$2.6M |
| Cash & equivalents | $6.7M | — | $361 | $1.1M | $3.1M |
| Inventory | $213,408 | — | $968 | $65,523 | $56,279 |
| Total assets | $84.2M | $104.9M | $12.5M | $3.7M | $5.8M |
| Total liabilities | $14.1M | $25.8M | $12.0M | $3.4M | $2.0M |
| Shareholders' equity | $70.1M | $79.1M | $542,353 | $763,136 | $3.8M |
Source: SEC EDGAR filings · CIK 0001382574 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.